                         SEQUENCE LISTING

<110>  Huff, Jeffrey  B.
       Hayden, Mark  A.
       Karabatsos, Peter  J.
       Schapals, Andrew  S.
       Muerhoff, Anthony  S.
       Felicia Bogdan, Maria  S.
       Leary, Thomas
       Holets-McCormack, Shelley  R.
       Laurenson, Sophie
       Fischer, Andrew  T.
       Haack, Richard
       Hershberger, Stefan
       House, Dustin
       Qiao, Lei
       Murphy, M. Shawn
       Pope, Mark  R.
       Prieto-Ballengee, Edna  M.
       Ruan, QiaoQiao
       Soni, Pathik
       Tetin, Sergey
       Yarnell, Lyle
 
<120>  DEVICES AND METHODS FOR SAMPLE ANALYSIS

<130>  12857WOO1

<150>  PCT/US16/25787
<151>  2016-04-02

<150>  US 62/187,704
<151>  2015-07-01

<150>  US 62/278,303
<151>  2016-01-13

<150>  US 62/279,488
<151>  2016-01-15

<160>  43    

<170>  PatentIn version 3.5

<210>  1
<211>  50
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide

<400>  1
agtcatacga gtcacaagtc atcctaagat accatacaca taccaagttc                  50


<210>  2
<211>  50
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide

<400>  2
gaacttggta tgtgtatggt atcttaggat gacttgtgac tcgtatgact                  50


<210>  3
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide

<400>  3
gcccagtgtc tttgtaggag gagcagcgcg tcaatgtggc tgacggacca tggcagatag       60


<210>  4
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide

<400>  4
ctatctgcca tggtccgtca gccacattga cgcgctgctc ctcctacaaa gacactgggc       60


<210>  5
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide


<220>
<221>  misc_binding
<222>  (1)..(1)
<223>  AlexaFluor 546

<400>  5
ctatctgcca tggtccgtca g                                                 21


<210>  6
<211>  27
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide

<400>  6
aaaaaaggtc cgcatcgact gcattca                                           27


<210>  7
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide

<400>  7
ccctcgtccc cagctacgcc t                                                 21


<210>  8
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide


<220>
<221>  misc_binding
<222>  (1)..(1)
<223>  AlexaFluor546

<400>  8
aggcgtagct ggggacgagg g                                                 21


<210>  9
<211>  15
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide

<400>  9
caagcccggt cgtaa                                                        15


<210>  10
<211>  15
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide


<220>
<221>  misc_binding
<222>  (1)..(1)
<223>  Maleimide

<400>  10
ttacgaccgg gcttg                                                        15


<210>  11
<211>  15
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide


<220>
<221>  misc_binding
<222>  (1)..(1)
<223>  AlexaFluor546

<400>  11
ttacgaccgg gcttg                                                        15


<210>  12
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  BINDING
<222>  (1)..(1)
<223>  Fmoc

<220>
<221>  BINDING
<222>  (5)..(5)
<223>  OH

<400>  12

Gly Ser Asn Lys Gly 
1               5   


<210>  13
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  BINDING
<222>  (1)..(1)
<223>  Fmoc

<220>
<221>  BINDING
<222>  (5)..(5)
<223>  OH

<400>  13

Gly Ser Asn Arg Gly 
1               5   


<210>  14
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  BINDING
<222>  (1)..(1)
<223>  Fmoc

<220>
<221>  BINDING
<222>  (5)..(5)
<223>  OH

<400>  14

Gly Ser Asn Asp Gly 
1               5   


<210>  15
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  BINDING
<222>  (1)..(1)
<223>  Fmoc

<220>
<221>  BINDING
<222>  (5)..(5)
<223>  OH

<400>  15

Gly Ser Asn Cys Gly 
1               5   


<210>  16
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  BINDING
<222>  (1)..(1)
<223>  Fmoc

<220>
<221>  BINDING
<222>  (5)..(5)
<223>  OH

<400>  16

Gly Ser Asn Met Gly 
1               5   


<210>  17
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  BINDING
<222>  (1)..(1)
<223>  Fmoc

<220>
<221>  BINDING
<222>  (5)..(5)
<223>  OH

<400>  17

Gly Ser Asn Tyr Gly 
1               5   


<210>  18
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  18

Gly Ser Asn Trp Gly 
1               5   


<210>  19
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  BINDING
<222>  (1)..(1)
<223>  Fmoc

<220>
<221>  BINDING
<222>  (5)..(5)
<223>  OH

<400>  19

Gly Ser Asn His Gly 
1               5   


<210>  20
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  BINDING
<222>  (1)..(1)
<223>  Fmoc

<220>
<221>  BINDING
<222>  (5)..(5)
<223>  OH

<400>  20

Gly Ser Asn Thr Gly 
1               5   


<210>  21
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  BINDING
<222>  (1)..(1)
<223>  Fmoc

<220>
<221>  BINDING
<222>  (5)..(5)
<223>  OH

<400>  21

Gly Thr Asn Ser Gly 
1               5   


<210>  22
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  BINDING
<222>  (1)..(1)
<223>  Fmoc

<220>
<221>  BINDING
<222>  (5)..(5)
<223>  OH

<400>  22

Gly Ser Gln Phe Gly 
1               5   


<210>  23
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  BINDING
<222>  (1)..(1)
<223>  Fmoc

<220>
<221>  BINDING
<222>  (5)..(5)
<223>  OH

<400>  23

Ile Ser Asn Lys Gly 
1               5   


<210>  24
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  BINDING
<222>  (1)..(1)
<223>  Fmoc

<220>
<221>  BINDING
<222>  (5)..(5)
<223>  OH

<400>  24

Ile Gly Ser Asn Lys Gly 
1               5       


<210>  25
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  25

Gly Ile Ser Asn Lys Gly 
1               5       


<210>  26
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  BINDING
<222>  (1)..(1)
<223>  Fmoc

<220>
<221>  BINDING
<222>  (10)..(10)
<223>  OH

<400>  26

Ala Glu Asp Val Gly Ser Asn Lys Gly Ala 
1               5                   10  


<210>  27
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  BINDING
<222>  (1)..(1)
<223>  Fmoc

<220>
<221>  BINDING
<222>  (9)..(9)
<223>  OH

<400>  27

Arg Pro Pro Gly Phe Ser Pro Phe Arg 
1               5                   


<210>  28
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  BINDING
<222>  (1)..(1)
<223>  Fmoc

<220>
<221>  BINDING
<222>  (5)..(5)
<223>  OH

<400>  28

Gly Ser Asp Phe Gly 
1               5   


<210>  29
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  BINDING
<222>  (1)..(1)
<223>  Fmoc

<220>
<221>  BINDING
<222>  (11)..(11)
<223>  OH

<400>  29

Cys Gly Arg Arg Ala Cys Gly Ser Asn Phe Gly 
1               5                   10      


<210>  30
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  BINDING
<222>  (1)..(1)
<223>  Fmoc

<220>
<221>  BINDING
<222>  (6)..(6)
<223>  FmocNH

<220>
<221>  BINDING
<222>  (7)..(7)
<223>  OH

<400>  30

Gly Ser Gly Asn Gly Lys Gly 
1               5           


<210>  31
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  azido homoalanine

<400>  31

Pro Pro His His His His His His Pro Pro Arg Gly Phe Gly Xaa Gly 
1               5                   10                  15      


Phe Arg 
        


<210>  32
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  32

Asp Arg Val Tyr Ile His Pro Phe 
1               5               


<210>  33
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  33

His Ser Asp Ala Val Phe Thr Asp Asn Tyr Thr Arg 
1               5                   10          


<210>  34
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  34

Tyr Thr Asp Ile Glu Met Asn Arg Leu Gly Lys 
1               5                   10      


<210>  35
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  35

Glu Asn Leu Tyr Phe Gln Ser 
1               5           


<210>  36
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  36

His His His His His His 
1               5       


<210>  37
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  37

Arg Lys Ile Ser Ala Trp Ala Gly Ile Ile Ala Val Pro Thr Met Ile 
1               5                   10                  15      


Ala Gly Ile Tyr Gly Met Asn Phe His Phe Met Pro Glu 
            20                  25                  


<210>  38
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  38

Asp Lys Thr His 
1               


<210>  39
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  39

Asp Lys Ser His 
1               


<210>  40
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Ser or Thr

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  positively charged aa

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  hydrophobic or positively charged aa

<400>  40

Xaa Xaa His Xaa 
1               


<210>  41
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  41

Ser Arg His Trp 
1               


<210>  42
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  (His)0-10

<400>  42

Gly Ser Pro Thr Gly Ala Ser Thr Xaa Gly Ser Pro Thr Gly Ala Ser 
1               5                   10                  15      


Thr 
    


<210>  43
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  43

Asp Tyr Lys Asp Asp Asp Asp Lys 
1               5               


